Stanford Is the Epicenter of Biomedical Innovation
Situated at the heart of Silicon Valley, it is no surprise that the Stanford School of Medicine in partnership with the Stanford School of Engineering and the Stanford Graduate School of Business has become the de facto leader in biomedical innovation. The Stanford Center for Biodesign (http://biodesign.stanford.edu) has developed a time-tested paradigm for the development of effective, value-based medical technologies. It offers coursework that is available for residents, fellows and medical students as well as engineering graduate students and MBA candidates.
We are privileged to include amongst our faculty Professor Emeritus and former department chairmen Dr. Mark Blumenkranz, who was honored with the Lifetime Innovator Award at the Ophthalmology Innovation Summit at the American Society of Retinal Specialists in 2017. Throughout his career Dr. Blumenkranz has pioneered many technologies that are now used routinely by vitreoretinal specialists and has been on the founding team of numerous startups including Adverum, Digisight, Macusight, Oculeve, Oculex, Optimedica, and Peak Surgical.
Drs. Blumenkranz and David Myung have recently established the Ophthalmology Innovation Program at the Byers Eye Institute where post-graduate fellows learn a disciplined approach to brining innovations in ophthalmic technology to market including identification of unmet needs, solution finding and business development in a project-based curriculum. This first-of a kind program includes collaboration with the Food and Drug Administration’s Division of Ophthalmic and Ear Nose and Throat Devices. Our second year retina fellow Dr. Zachary Bodnar, is the first graduate of this program.
Multiple members of the vitreoretinal service and other faculty at the Byers Eye Institute are involved in the development of ophthalmic technologies and entrepreneurship. There are great opportunities to work with our mentors on your existing or new ideas. Enquire about the formal program as well.